KLOTHO NEUROSCIENCES, INC.
July 24, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| RE: | Klotho Neurosciences, Inc. (the “Company”) | |
| Registration Statement on Form S-3 | ||
| File No. 333-288533 (the “Registration Statement”) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Klotho Neurosciences, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. ET on Friday, July 25, 2025, or as soon thereafter as is practicable, unless we or our outside counsel, Paul Goodman request by telephone that such Registration Statement be declared effective at some other time.
Please direct any questions regarding this filing to Paul Goodman, Esq at 917-596-0905.
| Very truly yours, | ||
| By: | /s/ Joseph Sinkule | |
| Name: | Joseph Sinkule | |
| Title: | Chief Executive Officer | |